
Mar 29, 2023
Apply to Join the Board as an Agency Member for 2023-2025
Executive Board – Apply to Join the Board as an Agency Member for 2023-2025
Would you like to help shape the future direction of the Association?
The Board comprises the following members:
- President
- Past President
- Up to 5 Industry Board members
- Up to 5 Agency Board members
Jan 04, 2023
Planning your Diary for 2023?
Take a look at what meetings are on offer from EPHMRA.
Here is the link for you to follow - https://vimeo.com/showcase/10090953

Jan 03, 2023
Dear Colleague(s)
Happy New Year and we hope you had a good festive break.
For our March News please do send us your company news - about people or services you would like to announce.
We produce our news in pdf format for the website - and we have over 2500 contacts on our international healthcare market research database.

Jan 03, 2023
Happy New Year to EPHMRA colleagues and friends.
Wishing you all a fantastic 2023.

Dec 20, 2022
Thank you very much for your support in 2022.
We would like to wish you all a great Festive Season and hope you are able to enjoy some time with family and friends.
Looking forward to reconnecting again in 2023.
Happy New Year!
The EPHMRA Team

Dec 14, 2022
MR Excellence Awards 2023 Open for entries
Take a look - details here on the website - https://www.ephmra.org/mr-excellence-awards
We have 3 MR Excellence Award categories -
1. Making a Business Impact
2. Innovative Approach
3. Future Leaders Case Study Award
The 2022 winners are below:
Dec 14, 2022
21 March 2023 is the new date of the UK meeting
The venue is: 30 Euston Square, London NW1 2FB
We’d like to thank our convenors for their hard work around bringing the meeting together for the membership:
- Anna Garofalo, Janssen
- John Grime, Strategic North
- Gayle Hughes, Pfizer
- Alex Marriott, Lumanity

Dec 09, 2022
Take a look at 3 member articles published on the website.

Dec 05, 2022
The venue is: 30 Euston Square, London NW1 2FB - 25th April 2023

Dec 05, 2022
EPHMRA Webinar
Speaker: Claire Jackson, Research Director, 7i Group Ltd
Convenor: David Twinberrow, Group Managing Director, Genactis
Overview: COVID-19 created unprecedented challenges for healthcare systems, specifically cancer.